Literature DB >> 18825722

Do we really need long-term hepatitis B hyperimmune globulin? What are the alternatives?

John R Lake1.   

Abstract

1. The outcomes of liver transplantation for patients with hepatitis are the best for any diagnosis. 2. Prevention of HBV re-infection is the key to excellent outcomes after liver transplantation. 3. The use of hepatitis B immunoglobulin to prevent HBV re-infection is effective, but costly and with side effects. 4. Effective prophylaxis against HBV re-infection can now be accomplished with combination nucleoside/nucleotide anti-virals.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18825722     DOI： 10.1002/lt.21637

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


  8 in total

1.  Prevention of post liver transplant HBV recurrence.

Authors:  Geoffrey W McCaughan
Journal:  Hepatol Int       Date:  2011-08-10       Impact factor: 6.047

2.  Inferior Outcomes Associated with the Coexistence of Hepatocellular Carcinoma Recurrence and Hepatic Virus Reinfection After Living Donor Liver Transplantation.

Authors:  Kun-Ming Chan; Tsung-Han Wu; Chih-Hsien Cheng; Chen-Fang Lee; Ting-Jung Wu; Hong-Shiue Chou; Wei-Chen Lee
Journal:  J Gastrointest Surg       Date:  2019-02-04       Impact factor: 3.452

3.  Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.

Authors:  Florian Bihl; Stefan Russmann; Vanina Gurtner; Loriana Di Giammarino; Loredana Pizzi-Bosman; Martine Michel; Andreas Cerny; Antoine Hadengue; Pietro Majno; Emiliano Giostra; Damiano Castelli; Gilles Mentha
Journal:  BMC Gastroenterol       Date:  2010-07-04       Impact factor: 3.067

4.  Hepatitis B immunoglobulin prophylaxis after liver transplantation: experience in a tertiary transplant centre.

Authors:  Joy Varghese; Deepti Sachan; Mettu S Reddy; Tom Cherian; Dinesh Jothimani; Kota Venugopal; Olithselvan Arikichenin; Rajasekar Perumalla; Gomathy Narasimhan; Vivekananthan Shanmugam; Srinivasan Vijaya; Jayanthi Venkataraman; Mohamed Rela
Journal:  J Clin Exp Hepatol       Date:  2014-08-13

Review 5.  Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation.

Authors:  Chrysoula Pipili; Evangelos Cholongitas
Journal:  World J Hepatol       Date:  2014-05-27

6.  Hepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana'a, Yemen.

Authors:  Hassan A Al-Shamahy; Samira H Hanash; Iqbal A Rabbad; Nameem M Al-Madhaji; Samarih M Naser
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

7.  Large fragment pre-S deletion and high viral load independently predict hepatitis B relapse after liver transplantation.

Authors:  Ting-Jung Wu; Tse-Ching Chen; Frank Wang; Kun-Ming Chan; Ruey-Shyang Soong; Hong-Shiue Chou; Wei-Chen Lee; Chau-Ting Yeh
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

8.  Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level.

Authors:  Gora Lô; Amina Sow-Sall; Halimatou Diop-Ndiaye; Ndiaye Babacar; Niokhar Ndane Diouf; Sokhna Moumi Daffé; Babacar Ndao; Moussa Thiam; Moustapha Mbow; Mamadou Bayo Soumboundou; Maud Lemoine; Maguette Sylla-Niang; Ousseynou Ndiaye; Cheikh Saad Boye; Souleymane Mboup; Ndeye Coumba Touré-Kane
Journal:  Pan Afr Med J       Date:  2019-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.